HIV News and Research

RSS

Blogs, opinion pieces recognize 1,000 day milestone until end of MDGs

April 5 marked 1,000 days until the end of the Millennium Development Goals, agreed to by the U.N. in 2000 as the world's first development agenda. International discussions are underway to determine the post-2015 development agenda.

9 Apr 2013

Blog summarizes discussion on HIV treatment for children under PEPFAR

The Center for Global Health Policy's "Science Speaks" blog describes "a public discussion [last] week of the Institute of Medicine's report" on PEPFAR, during which some experts raised the issue of HIV treatment for children.

9 Apr 2013

Research: HIV women infected with HPV are not protected by current vaccines

Women with HIV acquire cancer-causing forms of the human papillomavirus (HPV) that are not included in the current HPV vaccines Gardasil and Cervarix, according to new research from Fox Chase Cancer Center being presented at the AACR Annual Meeting 2013 on Sunday, April 7.

8 Apr 2013

Phase 3 study results of simeprevir in hepatitis C patients to be presented at EASL Congress

Janssen R&D Ireland announces that data will be presented on the investigational protease inhibitor simeprevir (TMC435) for the treatment of hepatitis C at The International Liver Congress 2013 of the European Association for the Study of the Liver, which will take place April 24 to 28 in Amsterdam, The Netherlands.

8 Apr 2013

Abstracts on Bristol-Myers Squibb's research in liver disease accepted for presentation

Bristol-Myers Squibb Company announced today that 14 abstracts on the Company's research in liver disease have been accepted for presentation at The International Liver CongressTM 2013, the 48th annual meeting of the European Association for the Study of the Liver, in Amsterdam, April 24 - 28.

8 Apr 2013

A*STAR's professor receives Szent-Gy-rgyi prize for groundbreaking cancer pill

Professor Alex Matter, Chief Executive Officer of A*STAR's Experimental Therapeutics Centre (ETC), has been awarded the 8th Annual Szent-Gy-rgyi Prize for Progress in Cancer Research by the National Foundation for Cancer Research (NFCR) for his contributions to the development of the first drug specifically targeting a molecular lesion in cancer.

7 Apr 2013

Student coalition ranks research universities' spending and activities on neglected diseases, other illnesses

"A first-time ranking of 54 top research universities in the United States and Canada has found that a miniscule percentage of funding goes to neglected diseases, despite the outsized influence that public universities play in developing medicines for illnesses often ignored by the private sector," Inter Press Service reports.

6 Apr 2013

Public health leaders file amicus brief in Supreme Court case challenging 'anti-prostitution pledge'

"The case of the 'anti-prostitution pledge' heading for the Supreme Court this month focuses on whether the requirement that groups funded by [PEPFAR] create policies 'explicitly' condemning prostitution is compatible with the First Amendment," the Center for Global Health Policy's "Science Speaks" blog reports.

6 Apr 2013

Vertex to conduct two Phase 2 studies of VX-135 in combination with daclatasvir

Vertex Pharmaceuticals Incorporated today announced it has entered into a non-exclusive agreement with Bristol-Myers Squibb Company to conduct Phase 2 studies of once-daily all-oral treatment regimens containing Vertex's nucleotide analogue hepatitis C virus polymerase inhibitor VX-135 and Bristol-Myers Squibb's NS5A replication complex inhibitor daclatasvir for the treatment of hepatitis C.

6 Apr 2013

Ending poverty within a generation may prove tougher than tackling AIDS, World Bank president warns

"The president of the World Bank has warned that ending the worst of global poverty within a generation would prove a tougher challenge than tackling AIDS, as he urged direct action to help more than a billion people benefit from growth," The Guardian reports.

6 Apr 2013

State Highlights: St. Jude lawsuits could change medical-device liability protection; Calif. weighs charity minimum for nonprofit hospitals

A raft of lawsuits filed Thursday against St. Jude Medical Inc. over an implanted heart device could challenge the broad liability protection that medical-device makers have enjoyed since a key Supreme Court ruling in 2008.

6 Apr 2013

Research roundup: Looking at CHIP to gauge effect of health law on doctors; Insurers' spending on quality improvements

In this study published by the Centers for Medicare & Medicaid Services, researchers analyzed the 1997 Children's Health Insurance Program to evaluate the potential changes in physicians' work hours in response to a large expansion in coverage.

6 Apr 2013

Advocates, community leaders to participate in Keep the Promise on HIV/AIDS March and Rally today

Hundreds of advocates and community leaders are expected to participate in the "Keep the Promise on HIV/AIDS" March and Rally on Saturday, April 6th beginning at 12:00 noon in Cadman Plaza Park in Brooklyn, New York.

6 Apr 2013

Researchers map immune response to HIV, say findings could inform vaccine science

In research that could help in the search for an HIV vaccine, "American researchers have minutely tracked one person's powerful immune response to the virus to see how a series of mutations led to an antibody that can defeat many HIV strains," the New York Times reports (McNeil, 4/3).

5 Apr 2013

Understanding ethics involved in selecting transplant candidates

Results from an anonymous survey of U.S. transplant providers report that incarceration, marijuana use, and psychiatric diagnoses, particularly suicide attempts, may lower patients' eligibility for liver transplantation.

5 Apr 2013

Roundup: Calif. hospitals to close after homeless care controversy; Texas hospitals spar over indigent care payments

Hospital owner Pacific Health Corp. said it will close its three remaining Southern California hospitals, citing the fallout from a federal fraud case last year in which the company admitted paying to recruit homeless people off skid row in Los Angeles and billing the government for unnecessary care (Terhune, 4/3).

5 Apr 2013

Observation of antibody evolution in HIV-1 patient provides insights into vaccine development

Observing the evolution of a particular type of antibody in an infected HIV-1 patient, a study spearheaded by Duke University, including analysis from Los Alamos National Laboratory, has provided insights that will enable vaccination strategies that mimic the actual antibody development within the body.

5 Apr 2013

Patients’ eligibility for liver transplantation may be lowered by incarceration, marijuana use, and psychiatric diagnoses

4 Apr 2013

Scientists develop new cancer immunotherapy treatment for children with high-risk solid tumors

Recently, research using adoptive T-cell immunotherapy in blood cancers have shown success, most notably in the case of a seven-year-old girl whose leukemia went into remission using altered T-cells and a disabled HIV virus.

4 Apr 2013

Same factor that helps fight off severe inflammatory ailments also functions as enemy

The same factor in our immune system that is instrumental in enabling us to fight off severe and dangerous inflammatory ailments is also a player in doing the opposite at a later stage, causing the suppression of our immune response.

4 Apr 2013

HIV News and Research

Blogs, opinion pieces recognize 1,000 day milestone until end of MDGs

Blog summarizes discussion on HIV treatment for children under PEPFAR

Research: HIV women infected with HPV are not protected by current vaccines

Phase 3 study results of simeprevir in hepatitis C patients to be presented at EASL Congress

Abstracts on Bristol-Myers Squibb's research in liver disease accepted for presentation

A*STAR's professor receives Szent-Gy-rgyi prize for groundbreaking cancer pill

Student coalition ranks research universities' spending and activities on neglected diseases, other illnesses

Public health leaders file amicus brief in Supreme Court case challenging 'anti-prostitution pledge'

Vertex to conduct two Phase 2 studies of VX-135 in combination with daclatasvir

Ending poverty within a generation may prove tougher than tackling AIDS, World Bank president warns

State Highlights: St. Jude lawsuits could change medical-device liability protection; Calif. weighs charity minimum for nonprofit hospitals

Research roundup: Looking at CHIP to gauge effect of health law on doctors; Insurers' spending on quality improvements

Advocates, community leaders to participate in Keep the Promise on HIV/AIDS March and Rally today

Researchers map immune response to HIV, say findings could inform vaccine science

Understanding ethics involved in selecting transplant candidates

Roundup: Calif. hospitals to close after homeless care controversy; Texas hospitals spar over indigent care payments

Observation of antibody evolution in HIV-1 patient provides insights into vaccine development

Patients’ eligibility for liver transplantation may be lowered by incarceration, marijuana use, and psychiatric diagnoses

Scientists develop new cancer immunotherapy treatment for children with high-risk solid tumors

Same factor that helps fight off severe inflammatory ailments also functions as enemy

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News